Over one million children around the world suffer from clubfoot, a treatable congenital birth defect that causes one or both feet to turn inward and upward. Documented throughout history, today clubfoot affects about 200,000 newborns each year.
Children who avail of the low-cost and efficient Ponseti Method treatment for clubfoot typically go on to live healthy active lives. Based in the US, MiracleFeet provides the Ponseti Method of treatment to children born with clubfoot around the world through partnerships with local healthcare providers.
Ranjeet and his son Pradeep were both born with clubfoot in India. “I was very sad that [my son] was born like me,” Ranjeet says, “I thought that he would have to suffer as I did.” Ranjeet brought his son to Wadia Children’s Hospital in Mumbai, which offers comprehensive and free-of-charge treatment to families in need, thanks to MiracleFeet. Within just a few weeks, two-year-old Pradeep was reaping the benefits of the treatment. “The first time he stood on his feet, I was so happy that I had no words,” says Ranjeet, “he walks a lot now, he can’t stay still!”
MiracleFeet helps empower local communities to treat clubfoot through training and by providing supplies such as braces, and it also works to establish systems to collect and analyse patient and clinic-level data to monitor quality and measure impact. By 2019, the organisation will have supported more than 50,000 children around the world. It works to expand access to proper treatment, including through early diagnosis, awareness campaigns and integrating clubfoot programmes in local health systems to promote lasting and sustainable change.
Recently, Oak gave MiracleFeet a grant for USD 5 million over five years to help end the disability caused by untreated clubfoot in low-income countries. This grant will support an ambitious 15-year plan in cooperation with the Global Clubfoot Initiative to end disability caused by clubfoot worldwide.
To find out more about the work of MiracleFeet or to read more inspiring stories, visit its website.